DexCom Revises 2025 Outlook, Announces New Product For Diabetics
Portfolio Pulse from Lekha Gupta
DexCom Inc has revised its 2025 financial targets, raising revenue outlook to $4.6-$5.1 billion and adjusted operating profit margin to 21%. The company also announced a new product for diabetics who don't use insulin, set to launch in the US in 2024.
June 26, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DexCom has raised its 2025 financial targets and announced a new product for diabetics who don't use insulin, set to launch in the US in 2024.
DexCom's raised financial targets and the announcement of a new product for a large market segment (non-insulin using diabetics) indicate a positive outlook for the company. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100